United States · Investor

curie.bio

Last cheque observed Oct 2026; 2 cheques on record.

AcceleratorDeploying nowLast fund $377M, Jun 2024

SeedSeries AGene TherapyTherapeuticsMedicine

Deploying now
100%of best year2cheques in 12 months, 2 on record
Since the last cheque11days00hrs00min00sec
Median round$99MCheque size, as they say$100K – $5.0MRounds led0 of 2
Pitch curie.bio

curie.bio highlights

  1. 01

    2 cheques in the last 12 months

  2. 02

    Mostly Series A: 100% of its rounds

What they do

Type
Accelerator (from a list, unverified)
Cheque size
$100K – $5.0M as they say
Stages
SeedSeries A
Sectors
Gene TherapyTherapeuticsMedicine
Based in
Boston, United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first2 appearances

  1. 2026

    2 rounds

  2. Oct
    Bolt BiotherapeuticsUS · Pulse 2.0$120MWith 11 others
  3. Mar
    R1 TherapeuticsSeries A · US · TechStartups$78MWith 5 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration3 named

ABAlexis BorisyManager of the Ultimate Managing MemberiFiling they signed
CLChristoph LengauerCsoiForm ADV
ZWZachary W WeinbergManager of the Ultimate Managing MemberiFiling they signed

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

$999Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
Legal name
Curie BIO Operations, LLC
SEC number
CRD 323682

Quick answers about curie.bio

What does curie.bio invest in?

curie.bio invests most often at Series A (100% of the rounds on record), in sectors such as Gene Therapy, Therapeutics and Medicine.

How active is curie.bio?

2 investments on record, 2 of them in the last 12 months. The most recent was in Oct 2026.

What has curie.bio invested in recently?

Its most recent investments on record: Bolt Biotherapeutics (Undisclosed round, Oct 2026) and R1 Therapeutics (Series A, Mar 2026).

How big are curie.bio's cheques?

The median round it joins is $99M. It says it writes cheques of $100K to $5.0M.

Is curie.bio investing now?

Yes: it is actively investing, with 2 investments in the last 12 months.

What kind of investor is curie.bio?

curie.bio is an accelerator based in Boston, United States.

How much does curie.bio manage?

About $999M, as gross assets of its private funds (Oct 2026).

Has curie.bio raised a new fund?

Its latest fund filing with the SEC was in Jun 2024, reporting $377M raised.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it